Company Filing History:
1 out of 8 
1 out of 2 Years Active: 2022
Title: **The Innovations of Inventor Xiaoping Tu in Coagulation Factors**
Introduction
Xiaoping Tu, an esteemed inventor based in Shanghai, China, has contributed significantly to the field of biopharmaceuticals with his groundbreaking innovations. With a particular focus on coagulation factors, Tu's research and development efforts culminated in an important patent that enhances the pharmacokinetics of human coagulation factor IX (FIX).
Latest Patents
Xiaoping Tu holds a notable patent, which details a hyperglycosylated recombinant human coagulation factor IX (FIX) fusion protein, alongside its preparation method and applications. This innovative fusion protein incorporates a human FIX, a flexible peptide linker, and a human chorionic gonadotropin β subunit carboxy-terminal peptide rigid unit, along with a half-life extending moiety. The result is a fusion protein that exhibits biological activity akin to recombinant FIX while significantly extending its in vivo activity half-life and minimizing immunogenicity, thereby improving both pharmacokinetics and pharmacodynamics.
Career Highlights
Throughout his career, Xiaoping Tu has been associated with prominent companies in the biopharmaceutical industry. Notable among these are Ampsource Biopharma Shanghai Inc. and Pharmab, Inc., where he has made remarkable contributions to the development of therapeutic drugs that enhance patient outcomes.
Collaborations
Xiaoping Tu has collaborated with talented individuals in his field, including Yongjuan Gao and Si Ruo Chen. These partnerships have fostered innovation and have been integral to advancing research and development in coagulation therapies.
Conclusion
Xiaoping Tu's contributions to the field of coagulation factors position him as an influential inventor whose work holds great potential for improving health outcomes. His unique fusion protein represents a significant advancement in biopharmaceutical technology, showcasing the impact of innovative thinking in medical science. As research continues, Tu's findings may pave the way for even more breakthroughs in the treatment of coagulation disorders.